Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Alveolar Proteinosis in Greece-Türkiye-Cyprus: Answers in a Real-Life Comparison.

Respirology (Carlton, Vic.)·2026
Same author

Clinical characteristics of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia.

ERJ open research·2026
Same author

The transcriptome of CD14<sup>+</sup>CD163<sup>-</sup>HLA-DR<sup>low</sup> monocytes predicts mortality in idiopathic pulmonary fibrosis.

The European respiratory journal·2025
Same author

Real-world evidence on long COVID-19 in Greece: A multicenter, cross-sectional study (LONCOV2).

IJID regions·2025
Same author

Fibrotic Disease of the Skin and Lung: Shared Pathways, Environmental Drivers, and Therapeutic Opportunities in a Changing Climate.

International journal of molecular sciences·2025
Same author

Initiation of antifibrotic treatment in fibrosing interstitial lung disease: is the clock ticking till proven progression?

European respiratory review : an official journal of the European Respiratory Society·2025

Related Experiment Video

Updated: May 31, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Stem cell therapy in pulmonary fibrosis.

Argyris Tzouvelekis1, Antonis Antoniadis, Demosthenes Bouros

  • 1Department of Pneumonology, Medical School, Democritus University of Thrace, Alexandroupolis, Greece.

Current Opinion in Pulmonary Medicine
|June 18, 2011
PubMed
Summary

Mesenchymal stem cells (MSCs) show promise for treating lung fibrosis and inflammation. Their immunomodulatory effects and differentiation capacity offer potential for lung tissue repair and regeneration in future clinical applications.

Related Experiment Videos

Last Updated: May 31, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Area of Science:

  • Regenerative Medicine
  • Pulmonary Medicine
  • Cell Therapy

Background:

  • Mesenchymal stem cells (MSCs) are being investigated for treating lung diseases.
  • Preclinical data on MSCs for lung fibrosis and inflammation have rapidly increased.
  • Understanding MSC mechanisms in lung repair is advancing.

Purpose of the Study:

  • To review current knowledge on MSCs in lung tissue repair and regeneration.
  • To highlight therapeutic perspectives and clinical applications of MSCs.
  • To focus on safety and efficacy trials for lung conditions.

Main Methods:

  • Review of preclinical data on MSCs in animal models of lung fibrosis and inflammation.
  • Analysis of current understanding of MSC mechanisms of action.
  • Examination of ongoing clinical trials for chronic lung diseases.

Main Results:

  • Limited preclinical and clinical studies exist for pulmonary fibrosis specifically.
  • MSCs demonstrate potential as regulators of tissue remodeling and immune response in lung fibrosis models.
  • Few clinical trials are underway for MSCs in chronic lung diseases.

Conclusions:

  • Adult MSCs offer a promising therapeutic option for lung tissue repair.
  • Key MSC properties include ready availability, immunomodulatory effects, and differentiation capacity.
  • Further research and clinical trials are needed to establish MSC efficacy in idiopathic pulmonary fibrosis.